Investors

RTO Investors Urged to Spearhead Legal Battle in Rentokil Initial plc Securities Fraud Case

by

London, UK – Rentokil Initial plc, a major player in the global pest control and hygiene services market, is currently embroiled in legal troubles as the company faces allegations of securities fraud. Investors are now being called upon to lead a class-action lawsuit, which seeks to address claims that the company might have misled shareholders about its financial health and business prospects. This legal action comes after significant fluctuations in Rentokil Initial’s stock prices, which some investors attribute to potentially undisclosed risks or misleading financial information provided by the company. The lawsuit aims to represent … Read more

Shaquille O’Neal Agrees to $11 Million Settlement for Injured Crypto Investors in NFT Lawsuit

by

MIAMI — On Tuesday, a federal judge in Miami gave the initial green light to an $11 million settlement fund, stemming from a class-action lawsuit involving famed former basketball player Shaquille O’Neal. This preliminary agreement addresses claims from investors who allege they suffered financial losses linked to the Astrals Project nonfungible tokens (NFTs) and GLXY tokens. The Moskowitz Law Firm, helmed by managing partner Adam Moskowitz in Coconut Grove, Florida, represents the certified class of affected investors. Moskowitz, alongside his colleague Joseph M. Kaye and the team from Mark Migdal Hayden, including Jose M. Ferrer … Read more

Deadline Approaching for Investors to Join Transocean Ltd. Securities Class Action Lawsuit, Allegations of Overstated Asset Valuations Surface

by

SAN DIEGO — A significant legal development has surfaced as Robbins Geller Rudman & Dowd LLP announces a deadline for the investors of Transocean Ltd. to assume a lead plaintiff role in a class-action lawsuit. The lawsuit, targeting the offshore drilling giant and several of its top executives, alleges violations of securities law spanning nearly a year, from October 31, 2023, to September 2, 2024. Investors who have suffered considerable losses during this specified period, formally known as the “Class Period”, are being urged to step forward by February 24, 2025, to potentially lead the … Read more

Opportunity Opens for APLT Investors to Spearhead Securities Fraud Legal Action Against Applied Therapeutics, Inc.

by

Investors who have purchased shares of Applied Therapeutics, Inc. may have a significant opportunity to lead a securities fraud lawsuit against the biopharmaceutical company. Applied Therapeutics, based in New York, is currently under scrutiny for alleged misleading statements and possible fraudulent activities related to the success and regulatory status of its developmental drug candidates. The focus of the allegations centers on the company’s lead product candidate, AT-007, a central nervous system penetrant Aldose Reductase inhibitor being developed for the treatment of Galactosemia, a rare pediatric metabolic disease. Concerns were raised after discrepancies were noted between … Read more